CD44 and breast cancer: Similar to OC, activation of JAK/STAT is important for the occurrence of BCSC, such as an increase in the CD44+/CD24low BCSC population observed in hypoxia, leading to the upregulation of genes that influence angiogenesis, proliferation, and EMT, further promoting BC development and chemoresistance [144,199].